HIGHLIGHTS
- who: Biochemical Target and collaborators from the Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Serbia Medical University (Sechenov University), Russia have published the research work: Bradykinin and Galectin-3 in Survived and Deceased Patients with COVID-19 Pneumonia: An Increasingly Promising Biochemical Target, in the Journal: Oxidative Medicine and Cellular Longevity of 27/Oct/2022
- what: The study aims at evaluating the possibility of using bradykinin and galectin-3 levels as early predictors that COVID-19 disease will progress into a severe case. The first part of the study focused on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.